IDXX vs LPCN · P/E 40, rev $2.36B vs rev $309.5K
IDEXX Laboratories Inc (IDXX) versus Lipocine Inc (LPCN) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. LPCN currently screens at market cap $19.3M.
Not investment advice. Open the IDXX and LPCN stock pages for the full models.
Not investment advice.